Skip to main content

vaccine Archives

Flulapalooza vaccination event set for Sept. 25

Aug. 15, 2013—Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination event that two years ago more than doubled the current world record for the total number of vaccinations given in an eight-hour period.

Read more


Study lays groundwork for rational T cell vaccine design

May. 30, 2013—Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response.

Read more


UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses

Nov. 12, 2012—Collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations in the coronavirus responsible for deadly severe acute respiratory syndrome (SARS) cripples the virus’s ability to cause disease in animals.

Read more


Protein’s length, flexibility key to infection

Oct. 31, 2012—The structural architecture of the reovirus attachment protein is required for efficient reovirus infection of host cells.

Read more


Additional volunteers needed for Flulapalooza Oct. 17 and 18

Oct. 10, 2012—Additional volunteers are needed Oct. 17 and 18 to assist with this year’s Flulapalooza, where Vanderbilt University and Medical Center faculty, staff, students and volunteers can quickly receive their flu vaccination during a mass flu vaccination plan. While exempt employees are encouraged to participate as volunteers, non-exempt employees also can participate in this event. All...

Read more


Flulapalooza set for Oct. 17-18

Oct. 3, 2012—Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination plan that last year more than doubled the then-world record for the total number of vaccinations given in an eight-hour period.

Read more


Long antibodies better against HIV

Jul. 19, 2012—Understanding how antibodies with long “loops” form may be important for HIV vaccine development.

Read more


Dengue antibodies give vaccine leads

Apr. 27, 2012—New information may help speed development of a vaccine or treatment for dengue fever.

Read more


Researchers spot Achilles’ heel in respiratory virus

Apr. 13, 2012—A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults.

Read more


On the tail of RSV infection mechanism

Feb. 15, 2012—New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

Read more


Diversity key in antibody repertoire

Oct. 7, 2011—Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.

Read more


Recent Stories from VUMC News and Communications Publications

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

Vanderbilt Medicine

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

VUMC campus

VUMC campus

Vanderbilt University School of Medicine entrance

Vanderbilt University School of Medicine entrance

Vanderbilt University Adult Hospital with helipad

Vanderbilt University Adult Hospital with helipad

more